RIGL

Equedia: Analyst Consensus and Insider Trades for Rigel Pharmaceuticals, Inc. - 11/03 - 01:15 PM ET

Rigel Pharmaceuticals Hits Weekly Low - 08/15 - 02:09 PM ET

Rigel Pharmaceuticals Breaks Support - 08/06 - 11:36 AM ET

Rigel Pharmaceuticals Begins Sliding Again On Increased Volume - 08/05 - 03:05 PM ET

Rigel Pharmaceuticals Sets Monthly Closing Low - 05/21 - 08:10 AM ET

The Maybach Review: Regel Pharmaceuticals Inc. Review in Progress - 03/27 - 12:07 PM ET

Rigel Pharmaceuticals Hits 2 1/2 Week High - 03/24 - 10:48 AM ET

The Maybach Journal: Has added Rigel Pharmaceuticals Inc. to their watch list - 02/26 - 11:50 AM ET

Rigel Pharma Appoints Daniel Magilavy As VP, Clinical Research - 02/26 - 09:39 AM ET

Rigel Pharma Names Daniel Magilavy VP, Clinical Research - 02/26 - 07:41 AM ET

Credit Suisse Reiterates Rigel Pharmaceuticals At Outperform With $36 Up From $25 Price Target - 02/13 - 11:25 AM ET

The Maybach Journal: Rigel Announces Fourth Quarter and Year End 2007 Financial Results - 02/12 - 12:01 PM ET

Rigel Pharma Q4 Loss Widens On Higher Expenses - Update - 02/12 - 08:39 AM ET

Rigel Pharma Q4 Net Loss Widens - Quick Facts - 02/12 - 07:54 AM ET

Rigel Reports Q4 Loss Of $0.61 Per Share - 02/12 - 07:34 AM ET

The Maybach Journal: Has added Rigel Pharmaceuticals Inc. to their watch list - 02/06 - 12:07 PM ET

Rigel Pharmaceuticals Drops To Four-Week Low - 02/06 - 11:22 AM ET

Rigel Pharmaceuticals Inc. (RIGL) Corporate Event Announcement Notice - 02/02 - 08:57 PM ET

Rigel Pharmaceuticals Inc. (RIGL) Corporate Event Announcement Notice - 02/01 - 09:24 PM ET

Rigel Pharmaceuticals Prices Public Offering Of 5 Mln Common Shares At $27/Share - Quick Facts - 01/31 - 08:53 PM ET

Page 1 of 2     1  2      Previous  |  Next

<< Back to Stock Index